Journal
CLINICA CHIMICA ACTA
Volume 495, Issue -, Pages 417-421Publisher
ELSEVIER
DOI: 10.1016/j.cca.2019.05.015
Keywords
Glycosylation; Glycosyltransferases; Cancers; MDR
Categories
Funding
- National Natural Science Foundation of China [31470799]
- Natural Science Foundation of Liaoning Province [20170540288]
- Special Fund of Dalian city for Distinguished Young Scholars [2017RJ07]
Ask authors/readers for more resources
Despite great progress in clinical treatment, cancer remains a serious health problem contributing to significant morbidity and mortality worldwide. Although chemotherapy is a common therapeutic measure, multidrug resistance (MDR) presents a major challenge that often leads to poor prognosis. The abnormal expression of glycosyltransferases (GTs) leading to aberrant glycosylation patterns are considered a marker of cancer. Furthermore, the biosynthesis of these glycoconjugates has been associated with tumor proliferation, invasion and metastasis. Recently, studies have found that GTs are involved in mediating MDR in cancer cells through complex mechanisms and can influence therapeutic effect. In this review, we focus on several types of cancers and summarize previous studies on the correlation between GTs and MDR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available